TB Research

Antitubercular therapy-induced psychosis

Bhanudeep Singanamalla, Lokesh Saini, Priyanka Madaan, Paramjeet Singh, Pankaj C. Vaidya, Jitendra Kumar Sahu

Neurology · 2019-12

Abstract

A 12-year-old girl with multidrug-resistant pulmonary tuberculosis presented with a 5-day history of headache and psychosis; at the time, she was taking a complex antitubercular therapy (ATT; kanamycin, levofloxacin, ethionamide, pyrazinamide, cycloserine, ethambutol) and pyridoxine. Examination revealed fluctuating sensorium and aggression. The differentials included neurotuberculosis, immune-reconstitution-inflammatory syndrome, and drug-induced psychosis. Neuroimaging revealed features of cycloserine-induced encephalopathy (CIE; figure 1, A–F). Cycloserine was replaced with linezolid and there was a complete resolution of the clinicoradiologic presentation over 4 weeks (figure 2, A–D), confirming the diagnosis.

MeSH terms

  • Cycloserine
  • Ethambutol
  • Pyrazinamide
  • Ethionamide
  • Psychosis
  • Medicine
  • Levofloxacin
  • Quetiapine
  • Pediatrics
  • Psychiatry